Stay updated on Inhaled Imatinib for PAH Clinical Trial

Sign up to get notified when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inhaled Imatinib for PAH Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision/version indicator has been updated from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:18:19.000Z thumbnail image
  2. Check
    19 days ago
    No Change Detected
  3. Check
    26 days ago
    Change Detected
    Summary
    UI/layout updates and metadata refresh were observed; no core study details appear to have changed.
    Difference
    0.0%
    Check dated 2026-04-05T05:57:17.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The core study details appear unchanged; only visual/layout differences are visible.
    Difference
    0.0%
    Check dated 2026-03-28T22:55:31.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a study location and removed Napoli, Italy, 80131. Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T16:18:18.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The IMPAHCT page now marks the study as terminated and adds a results summary. It states that AV-101 (inhaled imatinib) did not prove efficacy at any tested dose in PAH.
    Difference
    0.0%
    Check dated 2026-03-14T11:56:40.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T13:00:41.000Z thumbnail image

Stay in the know with updates to Inhaled Imatinib for PAH Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inhaled Imatinib for PAH Clinical Trial page.